InvestSMART

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.047

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$38 Notice of Extraordinary General Meeting/Proxy Form 30 Mar 2026 4:10PM $0.050 $0.047 fallen by 6%
$38 Key Milestones Achieved for First Victorian Empax Clinic 24 Mar 2026 9:43AM $0.038 $0.047 risen by 23.68%
$38 Emyria to Present at NWR Virtual Healthcare Conference 24 Mar 2026 9:31AM $0.038 $0.047 risen by 23.68%
$38 Record Half-Year Performance and National Expansion 26 Feb 2026 6:28PM $0.052 $0.047 fallen by 9.62%
$38 Appendix 4D and Half Year End Financial Report 26 Feb 2026 6:05PM $0.052 $0.047 fallen by 9.62%
$38 Application for quotation of securities - EMD 16 Feb 2026 7:24PM $0.057 $0.047 fallen by 17.54%
$38 Medibank Expands Funding to Emyria's Victorian Clinic 16 Feb 2026 8:40AM $0.054 $0.047 fallen by 12.96%
$38 Emyria Expands Investor Access Into Europe 12 Feb 2026 11:46AM $0.057 $0.047 fallen by 16.81%
$38 Application for quotation of securities - EMD 6 Feb 2026 8:17PM $0.051 $0.047 fallen by 7.84%
$38 Euroz Hartleys 2026 Healthcare Forum 5 Feb 2026 9:34AM $0.058 $0.047 fallen by 18.97%
$38 Application for quotation of securities - EMD 3 Feb 2026 7:16PM $0.059 $0.047 fallen by 20.34%
$38 Emyria's PTSD Program Delivers Lasting Recovery 2 Feb 2026 9:24AM $0.058 $0.047 fallen by 18.97%
$38 Emyria's Quarterly Investor Webinar 29 Jan 2026 3:46PM $0.057 $0.047 fallen by 17.54%
$38 December 2025 Quarterly Activities Report and Appendix 4C 28 Jan 2026 9:22AM $0.058 $0.047 fallen by 18.97%
$38 Application for quotation of securities - EMD 23 Jan 2026 7:16PM $0.061 $0.047 fallen by 22.95%
$38 Application for quotation of securities - EMD 20 Jan 2026 8:22AM $0.055 $0.047 fallen by 14.55%
$38 Change of Director's Interest Notice - M. Kaushal 12 Jan 2026 12:08PM $0.061 $0.047 fallen by 22.95%
$38 Application for quotation of securities - EMD 12 Jan 2026 12:02PM $0.061 $0.047 fallen by 22.95%
$38 Application for quotation of securities - EMD 9 Jan 2026 7:47PM $0.061 $0.047 fallen by 22.95%
$38 Notification of cessation of securities - EMD 31 Dec 2025 9:30AM $0.059 $0.047 fallen by 20.34%
$38 Section 708A(5)(e) Notice 19 Dec 2025 6:08PM $0.051 $0.047 fallen by 7.84%
$38 Application for quotation of securities - EMD 19 Dec 2025 6:01PM $0.051 $0.047 fallen by 7.84%
$38 Notification regarding unquoted securities - EMD 19 Dec 2025 6:00PM $0.051 $0.047 fallen by 7.84%
$38 Victorian Clinic Confirmed, National Rollout Proceeding 16 Dec 2025 9:08AM $0.052 $0.047 fallen by 9.62%
$38 Emyria's Perth Expansion a Template for East Coast Rollout 11 Dec 2025 9:08AM $0.053 $0.047 fallen by 11.32%

26 - 50 of 554 results

Page 2 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.